✦ LIBER ✦

Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

✍ Scribed by A.Koneti Rao; Craig Pratt; Andrew Berke; Allan Jaffe; Ira Ockene; Theodore L Schreiber; William R Bell; Genell Knatterud; Thomas L Robertson; Michael L Terrin

Book ID: 118413039
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 746 KB
Volume: 11
Category: Article
ISSN: 1558-3597
DOI: 10.1016/0735-1097(88)90158-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thrombolysis in myocardial infarction (T

Thrombolysis in myocardial infarction (TIMI) trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase

✍ Peake, Dwight E. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 133 KB

29 Fibrinolytic parameters and patency r

29 Fibrinolytic parameters and patency rate after thrombolysis with recombinant tissue plasminogen activator (rtPA) in patients with acute myocardial infarction (AMI)

✍ Huber, K.; Beckmann, R.; Resch, I.; Probst, P.; Binder, B.R. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 143 KB

A pilot trial of recombinant desulfatohi

A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial

✍ Christopher P. Cannon; Carolyn H. McCabe; Timothy D. Henry; Marc J. Schweiger; R 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 607 KB